Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (330)
Oruka Therapeutics, Inc. (ORKA)
Fairmount Funds Management LLC — Director
Shares
3,553,410
Price
$84.43
Total Value
$300.01M
Shares Held After
1,131,954
% of Holdings
75.8%
REGENXBIO Inc. (RGNX)
PAKOLA STEVE — Chief Medical Officer
Shares
36,725
Price
$12.86
Total Value
$472.28K
Shares Held After
213,009
% of Holdings
14.7%
Theravance Biopharma, Inc. (TBPH)
Samaha Eli — 10% Owner
Shares
37,799
Price
$17.00
Total Value
$642.63K
Shares Held After
9,174,453
% of Holdings
0.4%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
500
Price
$95.47
Total Value
$47.74K
Shares Held After
236,384
% of Holdings
0.2%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
2,263
Price
$94.75
Total Value
$214.41K
Shares Held After
236,884
% of Holdings
0.9%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
2,237
Price
$93.85
Total Value
$209.93K
Shares Held After
239,147
% of Holdings
0.9%
Axsome Therapeutics, Inc. (AXSM)
TABUTEAU HERRIOT — Director
Shares
49,666
Price
$240.25
Total Value
$11.93M
Shares Held After
7,229
% of Holdings
87.3%
Lexeo Therapeutics, Inc. (LXEO)
Otero Jose Manuel — Chief Operating Officer
Shares
4,666
Price
$4.48
Total Value
$20.90K
Shares Held After
137,482
% of Holdings
3.3%
Lexeo Therapeutics, Inc. (LXEO)
Townsend Richard Nolan — Director
Shares
25,947
Price
$4.48
Total Value
$116.24K
Shares Held After
377,817
% of Holdings
6.4%
Lexeo Therapeutics, Inc. (LXEO)
Bhalla Narinder Pal — Chief Medical Officer
Shares
22,306
Price
$4.42
Total Value
$98.59K
Shares Held After
82,194
% of Holdings
21.3%
Lexeo Therapeutics, Inc. (LXEO)
Tamayo Louis Edward — Chief Financial Officer
Shares
4,641
Price
$4.49
Total Value
$20.84K
Shares Held After
97,024
% of Holdings
4.6%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
700
Price
$52.13
Total Value
$36.49K
Shares Held After
73,389
% of Holdings
0.9%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
8,300
Price
$51.46
Total Value
$427.13K
Shares Held After
74,089
% of Holdings
10.1%
PRECIGEN, INC. (PGEN)
Thomasian Harry Jr. — Chief Financial Officer
Shares
171,429
Price
$5.53
Total Value
$948.00K
Shares Held After
354,535
% of Holdings
32.6%
Theravance Biopharma, Inc. (TBPH)
Samaha Eli — 10% Owner
Shares
25,027
Price
$17.13
Total Value
$428.79K
Shares Held After
9,212,252
% of Holdings
0.3%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
30,703
Price
$35.49
Total Value
$1.09M
Shares Held After
93,969
% of Holdings
24.6%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
27,872
Price
$35.48
Total Value
$988.89K
Shares Held After
58,750
% of Holdings
32.2%
Contineum Therapeutics, Inc. (CTNM)
Watkins Tim — CMO & Head of Development
Shares
10,833
Price
$16.02
Total Value
$173.59K
Shares Held After
8,961
% of Holdings
54.7%
Contineum Therapeutics, Inc. (CTNM)
Stengone Carmine N. — Director
Shares
10,000
Price
$16.01
Total Value
$160.08K
Shares Held After
17,217
% of Holdings
36.7%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
30,712
Price
$35.49
Total Value
$1.09M
Shares Held After
315,167
% of Holdings
8.9%
Tectonic Therapeutic, Inc. (TECX)
McNamara Peter — Chief Scientific Officer
Shares
172
Price
$35.00
Total Value
$6.02K
Shares Held After
55,285
% of Holdings
0.3%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
1,900
Price
$34.84
Total Value
$66.20K
Shares Held After
1,047,205
% of Holdings
0.2%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
23,100
Price
$34.26
Total Value
$791.48K
Shares Held After
1,049,105
% of Holdings
2.2%
ImmunityBio, Inc. (IBRX)
Selecky Christobel — Director
Shares
1,000
Price
$9.00
Total Value
$9.00K
Shares Held After
0
% of Holdings
100.0%
Monte Rosa Therapeutics, Inc. (GLUE)
Janku Filip — Chief Medical Officer
Shares
5,407
Price
$24.50
Total Value
$132.47K
Shares Held After
60,612
% of Holdings
8.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$549.27
Total Value
$131.82K
Shares Held After
40,513
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
14
Price
$546.60
Total Value
$7.65K
Shares Held After
40,753
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
66
Price
$545.96
Total Value
$36.03K
Shares Held After
40,767
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$543.30
Total Value
$239.05K
Shares Held After
40,833
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,081
Price
$542.62
Total Value
$586.57K
Shares Held After
41,273
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,499
Price
$541.60
Total Value
$1.35M
Shares Held After
42,354
% of Holdings
5.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,235
Price
$540.76
Total Value
$1.21M
Shares Held After
44,853
% of Holdings
4.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,309
Price
$539.93
Total Value
$706.77K
Shares Held After
47,088
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
988
Price
$538.51
Total Value
$532.04K
Shares Held After
48,397
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
518
Price
$537.75
Total Value
$278.55K
Shares Held After
49,385
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
110
Price
$536.28
Total Value
$58.99K
Shares Held After
49,903
% of Holdings
0.2%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
1,000
Price
$43.15
Total Value
$43.15K
Shares Held After
149,914
% of Holdings
0.7%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
3,308
Price
$42.17
Total Value
$139.51K
Shares Held After
150,914
% of Holdings
2.1%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
3,792
Price
$41.39
Total Value
$156.96K
Shares Held After
154,222
% of Holdings
2.4%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
1,900
Price
$40.09
Total Value
$76.17K
Shares Held After
158,014
% of Holdings
1.2%
BioAge Labs, Inc. (BIOA)
Barton Shane — Principal Accounting Officer
Shares
20,216
Price
$25.19
Total Value
$509.18K
Shares Held After
0
% of Holdings
100.0%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
7,026
Price
$18.53
Total Value
$130.22K
Shares Held After
1,203,784
% of Holdings
0.6%
X4 Pharmaceuticals, Inc (XFOR)
KIRSKE DAVID — Chief Financial Officer
Shares
8,543
Price
$4.26
Total Value
$36.43K
Shares Held After
167,750
% of Holdings
4.8%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
20,000
Price
$12.00
Total Value
$240.04K
Shares Held After
90,180
% of Holdings
18.2%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
200,000
Price
$35.45
Total Value
$7.09M
Shares Held After
1,748,403
% of Holdings
10.3%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
12,380
Price
$35.28
Total Value
$436.77K
Shares Held After
13,689,166
% of Holdings
0.1%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
12,380
Price
$35.28
Total Value
$436.77K
Shares Held After
13,689,166
% of Holdings
0.1%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
12,380
Price
$35.28
Total Value
$436.77K
Shares Held After
13,689,166
% of Holdings
0.1%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
17,000
Price
$26.82
Total Value
$455.90K
Shares Held After
614,321
% of Holdings
2.7%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
58,000
Price
$25.94
Total Value
$1.50M
Shares Held After
631,321
% of Holdings
8.4%
Showing 1–50 of 330 transactions (page 1 of 7)